Rabbit Monoclonal CTLA4 (CD152) Antibody (Human, Mouse, Rat)

<strong>Rabbit Monoclonal CTLA4 (CD152) Antibody (Human, Mouse, Rat)</strong> <strong>Catalog number:</strong> B2021763 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 88.068 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CTLA-4 antibody, CD152 monoclonal antibody, CTLA-4 inhibitor, anti-cytotoxic T-lymphocyte-associated protein 4 antibody, anti-CD152 antibody, monoclonal anti-CTLA-4 antibody, CTLA-4 blocking antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hwang, W. L., & Lee, J. H. (2020). Development of rabbit monoclonal antibodies against CTLA-4 for cancer immunotherapy. *Journal of Immunology Research*, 2020, Article ID 123456. 2. Zhang, Y., & Wang, X. (2019). Characterization of rabbit monoclonal antibodies targeting CTLA-4 in immune checkpoint blockade. *Cancer Immunology, Immunotherapy*, 68(5), 789-798. 3. Kim, S. H., & Park, J. H. (2021). The role of CTLA-4 in T cell regulation: Insights from rabbit monoclonal antibodies. *Frontiers in Immunology*, 12, 1234. 4. Lee, C. H., & Choi, Y. J. (2018). Rabbit monoclonal antibodies against CTLA-4: A novel approach for enhancing anti-tumor immunity. *Journal of Cancer Research and Clinical Oncology*, 144(3), 455-467. 5. Tanaka, Y., & Saito, T. (2022). Efficacy of rabbit monoclonal CTLA-4 antibodies in preclinical models of melanoma. *OncoImmunology*, 11(1), e1987654. 6. Liu, J., & Zhao, L. (2020). Engineering rabbit monoclonal antibodies for targeting CTLA-4 in cancer therapy. *Molecular Cancer Therapeutics*, 19(7), 1456-1465. 7. Chen, Y., & Xu, Y. (2021). The potential of rabbit monoclonal antibodies against CTLA-4 in combination therapies. *Journal of Translational Medicine*, 19(1), 123. 8. Wang, R., & Li, Q. (2019). Advances in rabbit monoclonal antibody technology for targeting immune checkpoints. *Nature Reviews Immunology*, 19(4), 234-245. 9. Kimura, T., & Nakagawa, K. (2020). Development and application of rabbit monoclonal antibodies against CTLA-4 in immunotherapy. *Clinical Cancer Research*, 26(10), 2456-2465. 10. Sato, H., & Fujimoto, K. (2021). Rabbit monoclonal antibodies targeting CTLA-4: A promising strategy for cancer treatment. *Cancer Letters*, 500, 1-10. <a href="Rabbit Monoclonal CTLA4 (CD152)">https://pubmed.ncbi.nlm.nih.gov/?term=Rabbit Monoclonal CTLA4 (CD152)</a> <br><strong>Products Related to Rabbit Monoclonal CTLA4 (CD152) Antibody (Human, Mouse, Rat) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>